CN104107204A - Medicinal composition for treating encephalatrophy and facial paralysis - Google Patents
Medicinal composition for treating encephalatrophy and facial paralysis Download PDFInfo
- Publication number
- CN104107204A CN104107204A CN201410387017.7A CN201410387017A CN104107204A CN 104107204 A CN104107204 A CN 104107204A CN 201410387017 A CN201410387017 A CN 201410387017A CN 104107204 A CN104107204 A CN 104107204A
- Authority
- CN
- China
- Prior art keywords
- parts
- facial paralysis
- brain atrophy
- years
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention belongs to the field of medicines, and particularly relates to a traditional Chinese medicament for treating encephalatrophy and facial paralysis. The medicinal composition is prepared from the following raw materials in parts by weight: 1-10 parts of ginseng, 1-10 parts of earthworm, 1-10 parts of leech and 1-10 parts of stiff silkworm, and is suitable for treating encephalatrophy, facial paralysis, muscle atrophy, neuratrophy, convulsion, joint pains, inhibited bending and stretching, cerebral apoplexy, epilepsy and other articular pains, is capable of stretching meridian and building bone, has a good drug effect, and does not have side effect.
Description
Technical field
The invention belongs to medicine field, particularly a kind of Chinese medicine for the treatment of brain atrophy and facial paralysis.
Background technology
At present, brain atrophy on market, the medicine of facial paralysis has, but effect is very undesirable, does not also find same effect, same recipe, and the curable especially medicine of drug effect.
Summary of the invention
The invention provides a kind of pharmaceutical composition for the treatment of brain atrophy and facial paralysis, be applicable to brain atrophy, facial paralysis, amyotrophy, stretches through strong bone, and neuratrophia, twitches, arthralgia, joint stuffiness, apoplexy, epilepsy, etc. arthromyodynia, good drug efficacy, has no side effect.
In order to realize goal of the invention, applicant provides following technical scheme:
.treat a pharmaceutical composition for brain atrophy and facial paralysis, made by the raw material of following weight part ratio:
Radix Ginseng 1-10 part, Pheretima 1-10 part, Hirudo 1-10 part, Bombyx Batryticatus 1-10 part;
Manufacture method:
Weight part ratio is broken into powder by raw material, then mix.
further:described medicine is made capsule.
Useful technique effect
Be applicable to brain atrophy, facial paralysis, amyotrophy, stretches through strong bone, and neuratrophia, twitches, arthralgia, joint stuffiness, apoplexy, epilepsy, etc. arthromyodynia, good drug efficacy, has no side effect.
Detailed description of the invention
The present invention will be further described below, to facilitate the technical staff to understand.
Embodiment 1: a kind of pharmaceutical composition for the treatment of brain atrophy and facial paralysis, made by the raw material of following weight part ratio:
1 part of Radix Ginseng, 1 part of Pheretima, 1 part of Hirudo, 1 part of Bombyx Batryticatus;
Manufacture method:
Weight part ratio is broken into powder by raw material, then mix.
Embodiment 2: a kind of pharmaceutical composition for the treatment of brain atrophy and facial paralysis, made by the raw material of following weight part ratio:
10 parts of Radix Ginsengs, 8 parts of Pheretimas, 9 parts of Hirudos, 10 parts of Bombyx Batryticatus;
Manufacture method:
Weight part ratio is broken into powder by raw material, then mix.
Embodiment 3: a kind of pharmaceutical composition for the treatment of brain atrophy and facial paralysis, made by the raw material of following weight part ratio:
8 parts of Radix Ginsengs, 10 parts of Pheretimas, 10 parts of Hirudos, 7 parts of Bombyx Batryticatus;
Manufacture method:
Weight part ratio is broken into powder by raw material, then mix.
embodiment 4: embodiment 1-3described medicine is made capsule.
Usage and dosage; Oral each 2 grams, every day 3 times.
Medication taboo; Anemia of pregnant woman's forbidding.
Cure case
1. Wang, man, 47 years old, before taking medicine, speak not clear, headache, through examination in hospital, slight brain atrophy, hospitalization, without any effect, is sought medical advice and medicine everywhere, has spent 10,000 polylith money, seek medical advice and medicine without any effect, took this formula after one month afterwards to my pharmacy, speak clear, headache has not had.Recover through examination in hospital.
2. Zhang, female, 50 years old, have a headache 3 years, make electroencephalogram and show brain atrophy, take at any time coffee and disperse, everybody knows that it is that pain relieving is not cured the disease that coffee disperses.Make referrals to my pharmacy through friend and take this formula 15 days, headache has not had, and 3 years are not repeatedly.
3. pond certain, female, 68 years old, facial paralysis, mouthful eye Guo is oblique, speaks not agile, hospitalization one month is invalid, being in life impact gos out that it is shy to be afraid of, causes thought pressure, takes this formula and after 3 months, recovers normal.
4. Wei, female, 35 years old, often plays Mah-Jong, stay up late, spirit is in tension at any time, once loses money in gamble and just feels suddenly tongue numbness within second day, to occur that mouthful eye Guo is oblique, do various failing to respond to any medical treatment, taken afterwards this and fill a prescription recovery in latter 2 months normally, not recurrence in 5 years.
5. Hao, man, 50 years old, open Carnis caprae seu ovis shop, often tired, have a rest bad, through examination in hospital brain atrophy, cause facial paralysis, because of increased turnover, delay treatment time, hear that afterwards my medicine is good, need not be in hospital, I have opened this formula medicine of 2 months, and to take rear recovery normal.
6. Chen, female, 20 years old, 2 years old time, must cross meningitis, after 3 days, there is epilepsy in hyperpyrexia severe coma, more than ten years fall ill frequently always, take this formula and extenuate morbidity half a year, within 2 years, cure afterwards.
7. dagger-axe, man, 60 years old, have a headache 30 years, use up all hedexs, without any effect, hospital does repeatedly and to check without any disease, eats coffee decentralised control always, afterwards in friend's introduction, take a rear week of this formula, headache is extenuated, transference cure after half a year, not recurrence in 2 years.
8. land, man, 61 years old, demobilized soldier, when the counterattack in self-defence, sleep in the open in moist field, the Laoshan, asaphia before taking medicine, walking disorder, hospital determines brain atrophy, in order to enjoy public health services, hospitalize 2 years, to no effect, took afterwards this formula and took effect for 3 months, within 1 year, recovered normal later.
9. Huang,, 40 years old, because job demand is on the drink, there is hypertension in man, brain atrophy, cerebral hemorrhage, Multiple Hospitalization, can only extenuate, often headache dim eyesight before taking medicine, take this formula and be clearly better after one month, within two months, cure, do not drink now, not recurrence in 5 years.
10. Zeng, man, 45 years old, brain atrophy hypertension 3 years, hypomnesis before taking medicine, walks undesired, to murmur to oneself, headache, mental disorder, loses work, and take this formula and recover afterwards for 1 year,
Efficacy evaluation;
In all healing cases, male 600 examples, female's 800 examples, the oldest 85 years old, minimal ages 20 years old, above 200 examples half a year of falling ill, 2 years above 500 examples, 3 years above 150 examples, brain atrophy 600 examples that hypertension causes, drink and cause 300 examples of brain atrophy, hyperpyrexia causes 250 examples of brain atrophy, 150 examples of epilepsy, facial paralysis 90 examples, the fastest two weeks of taking medicine, maximum duration 1 year, according to individual physical difference, determine to take medicine the course for the treatment of, after the recovery of taking medicine is normal, take medicine again and within one month, prevent recurrence, cure rate reaches 80%, effective percentage 85%
Without departing from the present invention, can also carry out various conversion and be equal to replacement the present invention, therefore, patent of the present invention be not limited to disclosed specific implementation process, and should comprise the whole embodiments that fall within the scope of the claims in the present invention.
Claims (2)
1. a pharmaceutical composition for the treatment of brain atrophy and facial paralysis, is characterized in that, is made up of the raw material of following weight part ratio:
Radix Ginseng 1-10 part, Pheretima 1-10 part, Hirudo 1-10 part, Bombyx Batryticatus 1-10 part;
Manufacture method:
Weight part ratio is broken into powder by raw material, then mix.
2. a kind of pharmaceutical composition for the treatment of brain atrophy and facial paralysis according to claim 1, is characterized in that, described medicine is made capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410387017.7A CN104107204A (en) | 2014-08-08 | 2014-08-08 | Medicinal composition for treating encephalatrophy and facial paralysis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410387017.7A CN104107204A (en) | 2014-08-08 | 2014-08-08 | Medicinal composition for treating encephalatrophy and facial paralysis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104107204A true CN104107204A (en) | 2014-10-22 |
Family
ID=51704324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410387017.7A Pending CN104107204A (en) | 2014-08-08 | 2014-08-08 | Medicinal composition for treating encephalatrophy and facial paralysis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104107204A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108635525A (en) * | 2018-07-28 | 2018-10-12 | 陕西惠福药业有限公司 | A kind of amber determines epilepsy capsule and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940675A (en) * | 2010-09-10 | 2011-01-12 | 重庆市南川区金佛山中药材品种培育研究所 | Chinese medicinal herb for treating facial neuritis |
CN101991638A (en) * | 2010-11-26 | 2011-03-30 | 潘畅 | Medicine composition for treating facial paralysis as well as preparation method and application thereof |
-
2014
- 2014-08-08 CN CN201410387017.7A patent/CN104107204A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940675A (en) * | 2010-09-10 | 2011-01-12 | 重庆市南川区金佛山中药材品种培育研究所 | Chinese medicinal herb for treating facial neuritis |
CN101991638A (en) * | 2010-11-26 | 2011-03-30 | 潘畅 | Medicine composition for treating facial paralysis as well as preparation method and application thereof |
Non-Patent Citations (4)
Title |
---|
崔应珉等: "温胆汤及其化裁方用验", 《中医学报》 * |
白金明: "内服中药配合针刺疗法治疗缺血性中风210例", 《辽宁中医要大学学报》 * |
郝现军等: "再谈水蛭活血方的应用心得", 《辽宁中医要大学学报》 * |
陈少玫等: "谢海洲教授治疗癫痫用药特点探析", 《中医药通报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108635525A (en) * | 2018-07-28 | 2018-10-12 | 陕西惠福药业有限公司 | A kind of amber determines epilepsy capsule and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104147288A (en) | Traditional Chinese medicine with the effects of soothing channels and invigorate blood circulation | |
CN104107204A (en) | Medicinal composition for treating encephalatrophy and facial paralysis | |
CN103285192A (en) | Traditional Chinese medicine preparation for treating epilepsy | |
CN104000995A (en) | Medicinal liquor for treating scapulohumeral periarthritis | |
US8668938B2 (en) | Composition and manufacturing processes of a toxicity free botanical drug for curative treatment of chronic diseases | |
CN102119971B (en) | Traditional Chinese medicine for treating coronary heart disease | |
CN102698012B (en) | Externally applied traditional Chinese medicine for treating oral lichen planus | |
CN103315989B (en) | A kind of pharmaceutical composition | |
Yasir et al. | Evaluation of Efficacy of Unani Regimen in the Management of post Stroke Spasticity, an open observational Study | |
CN102228587B (en) | Traditional Chinese medicine preparation for treating bone fracture | |
CN104208190A (en) | Medicament for treating facial paralysis | |
CN101361924B (en) | Chinese prepared medicine for treating rachitis | |
CN104306524A (en) | Medicament for treating peripheral facial paralysis | |
CN102961520B (en) | Pharmaceutical composition for treating arthritis and method for preparing pharmaceutical composition for treating arthritis | |
CN103301124B (en) | A kind of pharmaceutical composition for treating epilepsy | |
CN103520458A (en) | Pharmaceutical composition for soothing nerves in psychiatric nursing | |
CN104435343A (en) | Medicine for improving vision and preparation method of medicine | |
CN103585417B (en) | Agentiafor treating idiopathic trigeminal neuralgia | |
CN103655897B (en) | A kind of Chinese medicine composition treating prolapse of lumbar intervertebral disc | |
CN103301115B (en) | A kind of pharmaceutical composition for treating epilepsy | |
CN101985033B (en) | Compound traditional Chinese medicine for treating stubborn diseases | |
CN102805793B (en) | Oral Chinese medicinal pill for treating osteomyelitis | |
CN102233053A (en) | Traditional Chinese medicine pill for treating malaria | |
CN102872349A (en) | Asthma medicine | |
CN103830474A (en) | Traditional Chinese medicine for treating intestinal cysticercus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141022 |
|
WD01 | Invention patent application deemed withdrawn after publication |